0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Takeda Pharmaceutical Co Ltd ADR - Trending symbols

Latest News of Takeda Pharmaceutical Co Ltd ADR

DateTitleRead
2025-06-17
13:15
Global pharma stocks down as Trump renews tariff threatRead
2025-06-03
18:07
Takeda, Pfizer's Adcetrix wins EU approval for hodgkin lymphoma treatmentRead
2025-06-01
14:00
Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Polycythemia VeraRead
2025-05-20
19:33
Takeda Taps Salesforce (CRM) for AI-Driven Customer Experience PlatformRead



Trends

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Interest Income 150,34489,831240,175-28,504211,671-183,27128,400-76,618-48,217
Operating Income 723,907-720,2223,6851,512,3281,516,013-244,7091,271,304-1,426,196-154,891
Total Other Income Expense Net -301,21342,787-258,426-310,107-568,532120,895-447,6381,050,967603,329
Other Assets 62,747,6932,747,69940,5572,788,256-2,788,24313-19-6
Net Income from Continuing Operations 413,604384,694798,298-589,687208,611390,409599,020-920,426-321,406
Net Income Applicable to Common Shares 413,390384,761798,151-589,553208,598390,349598,947-920,748-321,801
Income before Tax 432,478285,447717,925-396,895321,031583,691904,721-1,547,787-643,066
Net Income 413,671384,480798,151-589,553208,598390,349598,947-920,748-321,801
Net Working Capital 3,090,593-450,8392,639,754-197,8712,441,88236,1632,478,045-3,057,535-579,490
Net Interest Income -168,954-50,880-219,834-65,332-285,1651,642-283,524320,07936,555
EBIT 88,249,000205,755,000294,004,000-198,716,00095,288,00015,453,000110,741,000-141,703,000-30,962,000

Comments

How you think about this?

Leave a comment

Stay informed about Takeda Pharmaceutical Co Ltd ADR.

Receive notifications about Takeda Pharmaceutical Co Ltd ADR in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.